Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1).
about
Identification of a WD40 repeat-containing isoform of PHIP as a novel regulator of beta-cell growth and survivalAngiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in miceMechanisms of action of glucagon-like peptide 1 in the pancreasThe Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes MellitusPotential roles of GPR120 and its agonists in the management of diabetesThe role of the p53 tumor suppressor in metabolism and diabetesDocosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathwaysSilencing mitogen-activated protein 4 kinase 4 (MAP4K4) protects beta cells from tumor necrosis factor-alpha-induced decrease of IRS-2 and inhibition of glucose-stimulated insulin secretionNADPH oxidase 2-derived reactive oxygen species mediate FFAs-induced dysfunction and apoptosis of β-cells via JNK, p38 MAPK and p53 pathways.PKCdelta blues for the beta-cellβ-cell mass in people with type 2 diabetes.Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass.Glucolipotoxicity of the pancreatic beta cell.Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.Glucose and fatty acids synergize to promote B-cell apoptosis through activation of glycogen synthase kinase 3β independent of JNK activation.Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion.Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans.Novel role for matricellular proteins in the regulation of islet β cell survival: the effect of SPARC on survival, proliferation, and signaling.Inhibition of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis.Protein tyrosine phosphatase-1B modulates pancreatic β-cell massMorin attenuates tau hyperphosphorylation by inhibiting GSK3β.Glucolipotoxicity impairs ceramide flow from the endoplasmic reticulum to the Golgi apparatus in INS-1 β-cellsFoxO feedback control of basal IRS-2 expression in pancreatic β-cells is distinct from that in hepatocytesSpecific glucose-induced control of insulin receptor substrate-2 expression is mediated via Ca2+-dependent calcineurin/NFAT signaling in primary pancreatic islet β-cells.Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function compound, HO-3867Imaging ectopic fat deposition in Caenorhabditis elegans muscles using nonlinear microscopy.Plastidial fatty acid levels regulate resistance gene-dependent defense signaling in ArabidopsisProtective role of oleic acid against cardiovascular insulin resistance and in the early and late cellular atherosclerotic process.Beta-cell mass plasticity in type 2 diabetes.A simple matter of life and death-the trials of postnatal Beta-cell mass regulationAICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms.Ectopic fat deposition contributes to age-associated pathology in Caenorhabditis elegans.On the role of IRS2 in the regulation of functional beta-cell mass.Cocaine- and amphetamine-regulated transcript (CART) protects beta cells against glucotoxicity and increases cell proliferation.Phosphatidylinositol-3,4,5-triphosphate and cellular signaling: implications for obesity and diabetes.Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate compositionUpdate on the protective molecular pathways improving pancreatic beta-cell dysfunctionGlucolipotoxicity: fuel excess and beta-cell dysfunction.Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction.
P2860
Q24320317-29EC2507-3F43-4CCE-9D38-C17DECA27EF7Q24523697-0BD4A0CA-1C9F-4475-B550-705829FF5F12Q24683764-9CC7074B-0CC5-49CB-A175-DA4A0DC29A71Q26766749-7F131ADD-9C6A-4849-A726-BC54F17F56CDQ26827101-D678AD6A-8A6C-4F7B-9EA6-ECC92F53DE86Q28079903-B28D514F-B9E2-4BE6-8DF6-7968DDDD760EQ28576771-56510BDE-D48A-4135-9B74-254A7B4DAF16Q28582459-A9FD0949-C8C1-466C-AA13-99F48420ACE6Q30994890-F7AA812C-9423-4FB0-AA12-194D3D46EE79Q33556440-9FEC5AB0-8401-4337-A650-8029A116EE12Q33558395-65B2F44B-BCDD-4FE8-9B9F-CED0DB933310Q33614014-A442A3FA-9CCE-4026-9035-B62859396383Q33665283-A9D4625E-4F34-4746-B4B9-A53803F744ADQ33865096-C0BF7ECB-861D-43BE-A0E6-02FD1AD8469CQ33889357-6B68905F-9EC3-46FF-8212-3BD4C08CDE25Q34231901-3745D8B0-E5F1-4105-AC68-46B24EB84F62Q34287799-7B7F341A-D0CD-471E-B5A0-B0C2815E6013Q34338020-8AF61A99-10AF-4EF0-A5B3-8444713C1547Q34431043-E64D67FB-A28E-4E7C-AA9E-ECB6B7A51FBFQ34512913-D6454B41-DC5C-4C2C-8756-A257CDD4395DQ35108980-DC92970E-400D-4A72-862B-7BC7AA96E8B0Q35196301-B47AE4E6-6199-4F60-A807-4DE570ACE141Q35371821-9929C612-37F6-4980-AE62-EF0C4773C078Q35405546-3F2DA4E5-6255-4AF0-9C59-C64342D84CC7Q35405586-C5C8FA4C-AFF1-451D-A637-A82DB2745DF5Q35429931-B2390137-AAD5-43FF-8BDE-AFC3BDA29F92Q35611093-E6DE935A-8CD5-463C-A689-A3F0D9A7DAFEQ35758488-DADF863A-E541-4D95-BA29-9C3F8FC2132BQ35763347-51247349-7A67-4A19-BCE9-83A8B8809361Q35852835-373BF886-7CD1-4D08-BFDE-C449FFFE5658Q35942505-BEA45985-F057-4A58-8A02-21FD8C4D3E08Q36090995-CC571A5D-B5ED-4D09-A1CD-EC407A138CDFQ36203731-0781E977-A06B-4294-9AC1-8E94ED718F5FQ36576524-F5D89A1A-0A79-4C6F-BC97-CBDEA093E004Q36579507-92160C4C-D89C-4864-A302-2531981B1293Q36702291-1732D84E-2748-4371-AC06-5E0DBC64C823Q36727408-96EDC81B-D352-4F02-B296-94603192927FQ36860811-5E8546B9-E22A-4E30-A6E7-C94B31DEF1C4Q36861036-B8CBD903-779F-428A-9DC1-FB1EC25603C2Q36906371-14A5DBB4-65A2-4428-8850-0AF3ADB822B0
P2860
Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1).
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Protein kinase B/Akt prevents ...... pancreatic beta-cells (INS-1).
@ast
Protein kinase B/Akt prevents ...... pancreatic beta-cells (INS-1).
@en
type
label
Protein kinase B/Akt prevents ...... pancreatic beta-cells (INS-1).
@ast
Protein kinase B/Akt prevents ...... pancreatic beta-cells (INS-1).
@en
prefLabel
Protein kinase B/Akt prevents ...... pancreatic beta-cells (INS-1).
@ast
Protein kinase B/Akt prevents ...... pancreatic beta-cells (INS-1).
@en
P2093
P2860
P356
P1476
Protein kinase B/Akt prevents ...... pancreatic beta-cells (INS-1).
@en
P2093
Christian E Wrede
Christopher J Rhodes
Isabelle Briaud
Lorna M Dickson
Melissa K Lingohr
P2860
P304
49676-49684
P356
10.1074/JBC.M208756200
P407
P577
2002-10-21T00:00:00Z